Career Panel

Sébastien Blais-Ouellette

Sébastien Blais-Ouellette is the founder and CEO of Photon etc. He is the cornerstone of Photon etc's business development and strategic planning. Sébastien also serves as the ambassador for the company, upholding its vision and advancing its mission. Furthermore, his long-term commitment to work-life balance has created a physically and mentally healthy corporate culture. Sébastien's vision of a better world and determination to make it happen to motivate his team to pursue ever more ambitious projects. Sébastien completed a master in sub-atomical particles at the University of Montreal and a Ph.D. in astrophysics in co-direction at the University of Montreal and the University of Aix-Marseille. Then, it is as a researcher in the astronomy department of the California Institute of Technology (Caltech) that he developed/perfected a technology using volume Bragg gratings to combine images and optical spectra of an object or sample in order to understand its nature. This is how Photon etc. is born from the desire to reveal features of the universe still invisible. Suspecting the potential of this filtre for microscopy, medicine, and the environment, Sébastien Blais-Ouellette decides to push the exploration by turning its instrument towards terrestrial applications. Since then, the way is clear for the birth of an outstanding company.
Marie-Christine Ferland

Marie-Christine Ferland is the general manager of Optonique, Quebec’s cluster of excellence in optics-photonics. She and her team organize activities ranging from trade missions to networking events. She has been working for more than 10 years in business development for renown photonics organizations such as INO and Leddartech. She also served on the boards of directors of several associations and held the position of Vice-President Innovative Manufacturer at Canadian Manufacturers & Exporters, an association that helps manufacturers grow.
Anthony Fradette

Dr. Anthony Fradette is a consultant in the Montréal office of the Boston Consulting Group (BCG). In this role, he has helped a print and digital media trade organization transitioning to the digital world, supporting the value creation strategy for a metals and mining company, forecasting wireless revenues for a telecom company and identifying procurement opportunities at a Canadian dairy company. Dr. Fradette enjoys working with large corporations and non-profit organizations to solve their most complex issues, and drive a direct impact on the economy and community around him. Prior to joining BCG, Dr. Fradette conducted research in particle physics, focusing on the detectability of dark matter models and new physics in the early universe.

Anthony obtained a PhD in theoretical physics from the University of Victoria, and a joint math and physics BSc degree at McGill. He is passionate about science outreach, trying new activities outside his comfort zone and speaks French and English.
Kimberly Girling

Kimberly Girling started her career as a scientist, earning a PhD in Neuroscience at the University of British Columbia where she developed novel therapeutics for Huntington's Disease, a neurodegenerative illness. During her work in science, she learned that good science must move beyond the bench, linking evidence to effective policies and accessible products. To this end, Kimberly developed a passion for science policy, leading her to work on a number of initiatives relating to health and drug policy, including work with the UBC Neglected Global Diseases Initiative, Universities Allied for Essential Medicines and the Canadian Drug Policy Coalition. In 2016, Kimberly was a member of the inaugural cohort of the Mitacs Canadian Science Policy Fellowship. She completed her fellowship with Defence Research and Development Canada, where she developed a new framework to identify ethical and policy barriers to the use of emerging technologies for human enhancement in the military. She has also worked as a policy analyst at Innovation, Science and Economic Development. As of January 2019, Kimberly is the Research and Policy Director at Evidence for Democracy, an Ottawa-based non-profit that promotes the transparent use of evidence in government decision-making.
John Kildea

John Kildea is a medical physicist at the McGill University Health Centre (MUHC) in Montreal and assistant professor in oncology at McGill University.

Dr. Kildea’s background is in astrophysics, with a PhD in high-energy astrophysics from University College Dublin and postdocs at McGill and at the Harvard-Smithsonian Center for Astrophysics. He transitioned into Medical Physics in 2010 and worked for seven years as a clinical medical physicist at the MUHC before joining McGill’s Gerald Bronfman Department of Oncology as an academic assistant professor in 2017.

As a medical physicist, Dr. Kildea’s research interests include neutron-induced carcinogenesis, quality and safety in radiation oncology, and health informatics. Dr. Kildea is vice-chair of the Canadian Partnership for Quality Radiotherapy, an alliance of the national professional associations involved in Canadian radiation oncology. Together with Dr. Tarek Hijal, Dr. Kildea co-leads the Opal patient portal project in Quebec (opalmedapps.com). Opal is currently in use at the MUHC and is being expanded to five other cancer centres in Montreal.